Ciongoli Gregory Austin reported RGNX

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002023732-26-000008

Machine-readable

Structured copy

Timestamps

Event (reported)

Aug 25, 2026

Published

Aug 27, 2026

Ingested by INSIDER

Nov 5, 02:20 UTC

Last re-read

Nov 5, 02:20 UTC

Extracted facts

Filer

Ciongoli Gregory Austin

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

REGENXBIO Inc. — Stock Options (Right to buy)

Ticker

RGNX

Shares

69.6K

Price per share

$0

Execution date (reported)

Aug 25, 2026

Owned after transaction

69.6K shares

Days from execution to publication

2

What this establishes

Ciongoli Gregory Austin filed this Form 4 reporting a grant or award of RGNX on Aug 25, 2026. It became public on Aug 27, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Ciongoli Gregory Austincik:0002023732

Issuer

REGENXBIO Inc.cik:0001590877

Revision history · 0

No field has changed since this record was first ingested.